Trial Profile
Phase Ia study of PRM 151 in volunteers and in patients with idiopathic pulmonary fibrosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2014
Price :
$35
*
At a glance
- Drugs Zinpentraxin alfa (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Promedior
- 16 Jan 2014 New trial record